Clarient, Inc. (NASDAQ:CLRT)

CAPS Rating: 4 out of 5

The Company is an advanced oncology diagnostics technology and services company. It combines innovative technologies and meaningful test results to improve outcomes of patients suffering from cancer.

Recs

0
Player Avatar war2128 (< 20) Submitted: 6/9/2007 6:30:41 PM : Outperform Start Price: $2.16 CLRT Score: +138.49

CLARIENT,INC Will be cash positive in the fourth quarter and will have double dighit growth in year 2007.

Featured Broker Partners


Advertisement